The New Science of Sharing

Companies such as Novartis and Intel are at the forefront of Science 2.0 by encouraging open systems of collaboration

Earlier this month, Swiss drugmaker Novartis did something rather unusual—and almost unheard of in the high-stakes, highly competitive world of Big Pharma. After investing millions trying to unlock the genetic basis of type 2 diabetes, the company released all of its raw data on the Internet. This means anyone (or any company) with the inclination is free to use the data—no strings attached.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.